A new set of investments by global health initiative UNITAID will revolutionise the HIV/AIDS response in low-income countries by bringing new and advanced HIV diagnostics to patients in the most remote communities.
UNITAID will be announcing one of the largest investments yet in these ‘point-of-care’ HIV diagnostics on July 23 at the International Aids Conference at Washington DC, along with its implementers for these projects: Médecins Sans Frontieres (MSF), UNICEF and the Clinton Health Access Initiative (CHAI).
Discussions will be held on how UNITAID’s unique market intervention approach will be used to accelerate market entry and reduce the price of technologies that move HIV diagnostics away from centralised testing facilities closer to the point of patient care. Experts will be available for interviews about these devises – both existing and emerging – which improve diagnosis, treatment and care of persons living with HIV and are suitable for resource-limited settings.
Speakers who will join the conference are Denis Broun, Executive Director, UNITAID; Teri Roberts, Diagnostics Advisor, MSF Access Campaign; Craig McClure, Chief, HIV/AIDS Section, UNICEF; David Ripin, Executive Vice President of Access Programmes and Chief Scientific Officer, CHAI.
EP News Bureau